Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02627079 · ClinicalTrials.gov registry record · NA
ICanSTEP : Increasing Physical Activity With Text Messaging
A NA study of A Diagnosis of Any Hematologic or Solid Malignancy, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT02627079 is a NA study of A Diagnosis of Any Hematologic or Solid Malignancy that has completed, run by Duke University. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02627079, a NA study of A Diagnosis of Any Hematologic or Solid Malignancy, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed pilot study will develop and test feasibility and preliminary efficacy of an exercise motivation intervention using a 12-week smartphone-text messaging program tailored to physical activity data retrieved from a Fitbit. Target population is 15 cancer survivors and 15 patients actively undergoing cancer treatment.
Conditions Studied
Interventions
- OTHER Daily SMS text messaging
Study Locations (1)
North Carolina
- Duke Cancer Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-08-04 |
| Est. Completion | 2018-05-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02627079
The ClinicalTrials.gov registry entry for NCT02627079 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with A Diagnosis of Any Hematologic or Solid Malignancy appearing as the primary indexed condition, and to 1 intervention - of which Daily SMS text messaging is the first listed.
NCT02627079 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT02627079 about?
NCT02627079 is a clinical study titled "ICanSTEP : Increasing Physical Activity With Text Messaging". The proposed pilot study will develop and test feasibility and preliminary efficacy of an exercise motivation intervention using a 12-week smartphone-text messaging program tailored to physical activity data retrieved from a Fitbit. Target population is 15 cancer survivors and 15 patients actively u...
What is the current status of trial NCT02627079?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-08-04. Estimated completion is 2018-05-21.
What conditions does trial NCT02627079 study?
This clinical trial studies the following conditions: A Diagnosis of Any Hematologic or Solid Malignancy.
What interventions are being tested in trial NCT02627079?
The interventions under investigation include: Daily SMS text messaging (OTHER).
Who is sponsoring clinical trial NCT02627079?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02627079 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.